Blog
Understanding CD152/CTLA-4 Mechanisms and the Success of FDA Approved Checkpoint Inhibitors
Alpha Lifetech consistently provides critical support for mechanistic research and drug development related to disease targets.
Overcoming the long cycle of traditional SELEX? Capillary Electrophoresis enables rapid screening of aptamers
Alpha Lifetech leverages CE-SELEX technology to significantly shorten the screening cycle, delivering pM-level high-affinity aptamers from target preparation to affinity validation.
Synthetic Quality Control: The Backbone of Reliable Peptide Library Services
Alpha Lifetech’s comprehensive platform encompasses the Phage Display Peptide Library Construction Platform for building high-diversity, high-quality libraries for target-binding peptides.
Optimizing Diagnostics: The Advantages of Aptamers over Antibodies
Alpha Lifetech provides a fully integrated Aptamer Development Platform, enabling efficient selection and refinement of high-affinity aptamers.
Stability and Expression: Why VHH Antibodies Excel in Diagnostic Applications
Alpha Lifetech provides high-quality, comprehensive VHH Antibody Discovery Services, covering the entire workflow from immunogen preparation, VHH library construction, VHH library screening.
4-1BBL (CD137L/TNFSF9): Ligand Structure, Signal Activation, and Analysis of Drug Development Strategies
The evolving understanding of the 4-1BBL pathway is now enabling the development of safer, precision-guided immunotherapies aimed at seamlessly integrating costimulation into oncology care.
Application of Yeast Display Technology in Antigen-Antibody Interactions and Epitope Characterization
Alpha Lifetech offers a comprehensive suite of Yeast Display technologies to accelerate your protein engineering and antibody discovery projects.
From Library to Ligand: A Step-by-Step Guide to the SELEX Process
Alpha Lifetech’s services includes Aptamer Synthesis Platform, Aptamer Screening Platform, and Aptamer Optimization Service, enabling efficient selection and refinement of high-affinity aptamers.
Targeting OX40 (CD134/TNFRSF4/Txgp1): A Co-stimulatory Pathway in Cancer Immunotherapy
Alpha Lifetech offer high-quality Protein Expression and Purification Services to ensure the correct folding and biological activity of complex transmembrane proteins like OX40.
RNA Aptamer vs. DNA Aptamer: Choosing the Right Molecule for Your SELEX Strategy
Alpha Lifetech provides a specialized SELEX platform for aptamers, focusing on the custom development of both RNA and DNA aptamers to facilitate scientific research and outcomes translatiion.